Evidence map›Paper›PMID 27783043›Full record

ArticleInternational journal of molecular sciences2016

Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia.

Julio Jiménez, Jute Richter, Taro Nagatomo, Thomas Salaets, Rozenn Quarck, Allard Wagennar, Hongmei Wang, Jeroen Vanoirbeek, Jan Deprest, Jaan Toelen

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prematurity and Hyperoxia Have Different Effects on Alveolar and Microvascular Lung Development in the Rabbit.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Julio JiménezDepartment of Development and Regeneration, Group Biomedical Sciences, KU Leuven, 3000 Leuven, Belgium. juliojimenez@gmail.com.
Jute RichterDepartment of Development and Regeneration, Group Biomedical Sciences, KU Leuven, 3000 Leuven, Belgium. jute.richter@uzleuven.be.
Taro NagatomoDepartment of Pediatrics, Ehime Prefectural Central Hospital, 790-0024 Ehime, Japan. ctnagatomo@gmail.com.
Thomas SalaetsDepartment of Development and Regeneration, Group Biomedical Sciences, KU Leuven, 3000 Leuven, Belgium. thomas.1.salaets@uzleuven.be.
Rozenn QuarckRespiratory Division, Department of Clinical and Experimental Medicine, University of Leuven, 3000 Leuven, Belgium. Rozenn.Quarck@kuleuven.be.
Allard WagennarRespiratory Division, Department of Clinical and Experimental Medicine, University of Leuven, 3000 Leuven, Belgium. allard.wagenaar@kuleuven.be.
Hongmei WangDepartment of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, 250021 Jinan, China. whmeisd@163.com.
Jeroen VanoirbeekCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, 3000 Leuven, Belgium. Jeroen.Vanoirbeek@kuleuven.be.
Jan DeprestDepartment of Development and Regeneration, Group Biomedical Sciences, KU Leuven, 3000 Leuven, Belgium. jan.deprest@uzleuven.be.
Jaan ToelenDivision of Woman and Child, University Hospitals Leuven, 3000 Leuven, Belgium. jaan.toelen@uzleuven.be.
KU Leuven · BEEhime Prefectural Central Hospital · JPShandong University · CNUniversidad del Desarrollo · CLUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is caused by preterm neonatal lung injury and results in oxygen dependency and pulmonary hypertension. Current clinical management fails to reduce the incidence of BPD, which calls for novel therapies. Fetal rabbits have a lung development that mimics humans and can be used as a translational model to test novel treatment options. In preterm rabbits, exposure to hyperoxia leads to parenchymal changes, yet vascular damage has not been studied in this model. In this study we document the early functional and structural changes of the lung vasculature in preterm rabbits that are induced by hyperoxia after birth. Pulmonary artery Doppler measurements, micro-CT barium angiograms and media thickness of peripheral pulmonary arteries were affected after seven days of hyperoxia when compared to controls. The parenchyma was also affected both at the functional and structural level. Lung function testing showed higher tissue resistance and elastance, with a decreased lung compliance and lung capacity. Histologically hyperoxia leads to fewer and larger alveoli with thicker walls, less developed distal airways and more inflammation than normoxia. In conclusion, we show that the rabbit model develops pulmonary hypertension and developmental lung arrest after preterm lung injury, which parallel the early changes in human BPD. Thus it enables the testing of pharmaceutical agents that target the cardiovascular compartment of the lung for further translation towards the clinic.

Indexed as

AnimalsAnimals, NewbornBronchopulmonary DysplasiaDisease Models, AnimalHumansHyperoxiaHypertension, PulmonaryLungPulmonary AlveoliPulmonary ArteryRabbitsRespiratory Function Testsanimal modelsbronchopulmonary dysplasialung chronic diseaselung functionrabbit

Identifiers

PMID27783043
PMCPMC5085800
OpenAlexW2532701723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.